United Kingdom· GB-APID-38754811000001103
Nilemdo 180mg tablets
A bempedoic acid product containing bempedoic acid, registered in United Kingdom by Daiichi Sankyo UK Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Bempedoic acid is registered in 13 of 19 countries.
Countries holding a registration under ATC C10AX15 (bempedoic acid), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Bempedoic acid · ATC C10AX15
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bempedoic acid costs, country by country.
Normalised to the WHO defined daily dose (0.18 g), the median price runs from $2.64 in Switzerland to $4.54 in Italy — a ×1.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bempedoic acid · price per daily dose (0.18 g)
USD · FX 28 Sept 2026
- IT Italy$4.54
- CH Switzerland$2.64
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Bempedoic acid
- Manufacturer
- Daiichi Sankyo UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- C10AX15
- ATC class
- Bempedoic acid
- Defined daily dose
- 0.18 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5015494000073
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
35 interactions on record for bempedoic acid.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bempedoic acid · interactions on record
35 records
- 20 severe
- 15 moderate
Most severe, free to view
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- PrednisoneA07EA03severe
- BetamethasoneA07EA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bempedoic acid in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayNilemdoDaiichi Sankyo
- CzechiaNILEMDODaiichi Sankyo Europe GmbH, Mnichov
- ItalyNILEMDO*28 cpr rivestite 180 mgFARMED Srl
- BelgiumNilemdo 180 mgDaiichi Sankyo Europe
- SwitzerlandNilemdo 180 mg, FilmtablettenDaiichi Sankyo (Schweiz) AG
- IrelandNilemdo 180 mg film-coated tabletsDaiichi Sankyo Europe GmbH
- United StatesNexletolEsperion Therapeutics, Inc.
- IcelandNilemdoDAIICHI SANKYO EUROPE GmbH*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nilemdo
- Liechtenstein · Nilemdo
- Norway · Nilemdo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4eac6a39-55de-45f0-8238-f74e82e61fcb GET /v1/drugs/4eac6a39-55de-45f0-8238-f74e82e61fcb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "38754811000001103",
"desc": "Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd)",
"form": "Oral tablet",
"vpid": "38931511000001109",
"source": "dmd",
"vtm_id": "870610007",
"strength": "180 mg",
"substance": "Bempedoic acid",
"ingredient": "Bempedoic acid",
"supplier_code": "2081301000001107"
}See everything about bempedoic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.